Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Prognosis of Metaplastic Breast Cancer: A Population‐Based Matched Cohort Study | Synapse

March 3, 2026Cancer Medicine0 citationsOpen Access

View Full Paper

Prognosis of Metaplastic Breast Cancer: A Population‐Based Matched Cohort Study

MBMarie BergmanÖrebro University ASAglaia SchizaUppsala University CBCeren BoyacıKarolinska University Hospital

Key Points

Survival outcomes for metaplastic breast cancer may be comparable to other breast cancer types.
Larger observational studies with longer follow-up periods are necessary to confirm these findings.
Population-based analysis highlights the importance of appropriate treatment in metaplastic breast cancer outcomes.
Calls for further research to improve understanding of metaplastic breast cancer prognosis.

Abstract

With appropriate treatment, metBC may have survival outcomes comparable to NST. Larger studies with longer follow-up are needed to provide further insights.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Bergman et al. (Wed,) studied this question.

synapsesocial.com/papers/69a75bb6c6e9836116a238be https://doi.org/https://doi.org/10.1002/cam4.71570

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials2019 · 398 citations
2Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials2023 · 167 citations
3Hormone Receptor Status Does Not Affect Prognosis in Metaplastic Breast Cancer: A Population-Based Analysis with Comparison to Infiltrating Ductal and Lobular Carcinomas2014 · 66 citations
4Metaplastic breast carcinoma: more than a special type2014 · 102 citations
5Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline <i>BRCA</i> Pathogenic Variant2019 · 198 citations